|
| NO-1886 Basic information |
Product Name: | NO-1886 | Synonyms: | OPF 009;Lipoprotein Lipase Activator;NO-1886;Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate;4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide;ibrolipim;Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate, Ibrolipim, OPF 009;Ibrolipim NO-1886 | CAS: | 133208-93-2 | MF: | C19H20BrN2O4P | MW: | 451.25 | EINECS: | | Product Categories: | | Mol File: | 133208-93-2.mol | |
| NO-1886 Chemical Properties |
Melting point | 160.5-162.1 °C | Boiling point | 512.5±50.0 °C(Predicted) | density | 1.44±0.1 g/cm3(Predicted) | storage temp. | Sealed in dry,2-8°C | solubility | DMSO: ≥20mg/mL | form | powder | pka | 11.51±0.70(Predicted) | color | off-white to pale yellow |
| NO-1886 Usage And Synthesis |
Uses | Lipoprotein Lipase Activator is an inducer of lipoprotein lipase mRNA. | Uses | Antiatherogenic; antiobesity;
antidyslipidemia; anticachexia; and antidiabetes/syndrome. |
| NO-1886 Preparation Products And Raw materials |
|